Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Skin biopsy is crucial for diagnosing unknown baldness causes.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Current treatments for alopecia show no significant long-term benefits.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Proper diagnosis and treatment of childhood hair loss require distinguishing between alopecia and trichotillomania.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

People with alopecia areata often have thyroid autoimmunity.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.